Intervention Review

You have free access to this content

Dexmedetomidine for the management of awake fibreoptic intubation

  1. Xing-Ying He1,
  2. Jian-Ping Cao2,
  3. Qian He3,
  4. Xue-Yin Shi1,*

Editorial Group: Cochrane Anaesthesia, Critical and Emergency Care Group

Published Online: 19 JAN 2014

Assessed as up-to-date: 9 MAY 2012

DOI: 10.1002/14651858.CD009798.pub2


How to Cite

He XY, Cao JP, He Q, Shi XY. Dexmedetomidine for the management of awake fibreoptic intubation. Cochrane Database of Systematic Reviews 2014, Issue 1. Art. No.: CD009798. DOI: 10.1002/14651858.CD009798.pub2.

Author Information

  1. 1

    Changzheng Hospital, The Second Military Medical University, Department of Anaesthesiology, Shanghai, China

  2. 2

    455 Hospital of the PLA, Department of Anaesthesiology, Shanghai, China

  3. 3

    The Second Military Medical University, Department of Health Statistics, Faculty of Health Services, Shanghai, China

*Xue-Yin Shi, Department of Anaesthesiology, Changzheng Hospital, The Second Military Medical University, Fengyang Road 415, Shanghai, 200003, China. shixueyin1128@163.com.

Publication History

  1. Publication Status: New
  2. Published Online: 19 JAN 2014

SEARCH

References

References to studies included in this review

  1. References to studies included in this review
  2. References to studies excluded from this review
  3. References to studies awaiting assessment
  4. Additional references
  5. References to other published versions of this review
Bergese 2010a {published data only}
  • Bergese SD, Patrick Bender S, McSweeney TD, Fernandez S, Dzwonczyk R, Sage K. A comparative study of dexmedetomidine with midazolam and midazolam alone for sedation during elective awake fiberoptic intubation. Journal of Clinical Anesthsia 2010;22(1):35-40. [MEDLINE: 20206849]
Bergese 2010b {published data only}
  • Bergese SD, Candiotti KA, Bokesch PM, Zura A, Wisemandle W, Bekker AY. A Phase IIIb, randomized, double-blind, placebo-controlled, multicenter study evaluating the safety and efficacy of dexmedetomidine for sedation during awake fiberoptic intubation. American Journal of Therapeutics 2010;17(6):586-95. [MEDLINE: 20535016]
Chu 2010 {published data only}
  • Chu KS, Wang FY, Hsu HT, Lu IC, Wang HM, Tsai CJ. The effectiveness of dexmedetomidine infusion for sedating oral cancer patients undergoing awake fibreoptic nasal intubation. European Journal of Anaesthesiology 2010;27(1):36-40. [MEDLINE: 19550337]
Tsai 2010 {published data only}

References to studies excluded from this review

  1. References to studies included in this review
  2. References to studies excluded from this review
  3. References to studies awaiting assessment
  4. Additional references
  5. References to other published versions of this review
Boyd 2011 {published data only}
  • Boyd BC, Sutter SJ. Dexmedetomidine sedation for awake fiberoptic intubation of patients with difficult airways due to severe odontogenic cervicofacial infections. Journal of Oral and Maxillofacial Surgery 2011;69:1608-12. [MEDLINE: 21392875]
Swaniker 2011 {published data only}
  • Swaniker J, Glick D. The impact of adjunct dexmedetomidine use on opioid requirements and hemodynamic stability during awake fiberoptic intubation. 2011 Annual Meeting of the International Anesthesia Research Society, IARS 2011, Vancouver, BC, Canada. [conference proceedings]

References to studies awaiting assessment

  1. References to studies included in this review
  2. References to studies excluded from this review
  3. References to studies awaiting assessment
  4. Additional references
  5. References to other published versions of this review
Cattano 2012 {published data only}
  • Cattano D, Lam NC, Ferrario L, Seitan C, Vahdat K, Wilcox DW, et al. Dexmedetomidine versus remifentanil for sedation during awake fiberoptic intubation. Anesthesiology Research and Practice [electronic resource] 2012;Epub Jul 16. [MEDLINE: 22844277]
Hu 2013 {published data only}
  • Hu R, Liu JX, Jiang H. Dexmedetomidine versus remifentanil sedation during awake fiberoptic nasotracheal intubation:a double-blinded randomized controlled trial. Journal of Anesthesia 2013;27:211-7. [MEDLINE: 23073729]
Li 2012 {published data only}
  • Li XB, Liu HQ, Meng XY, Yuan T, Han W, Tong T, et al. Application of dexmedetomidine combined with fibreoptic bronchoscope for tracheal intubation in difficult airways caused by huge goiter. Journal of Jilin Universtiy (Medical Edition) 2012;38:328-32.
Qiu 2013 {published data only}
  • Qiu L, Zhang L, Ji J. Sedation effect of dexmedetomidine on awake intubation in patients with difficult airway. Pharmaceutical Care and Research 2013;13:208-12.

Additional references

  1. References to studies included in this review
  2. References to studies excluded from this review
  3. References to studies awaiting assessment
  4. Additional references
  5. References to other published versions of this review
Abdelmalak 2007
Bailey 1990
Bergese 2007
Coursin 2001
  • Coursin DB, Coursin DB, Maccioli GA. Dexmedetomidine. Current Opinion in Critical Care 2001;7:221-6. [MEDLINE: 11571417]
Ebert 2000
Gerlach 2007
Grant 2004
Hall 2000
Higgins 2011
  • Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane-handbook.org.
Jooste 2005
Juni 2001
Kamibayashi 2000
Knolle 2003
Lallo 2009
Machata 2003
  • Machata AM, Gonano C, Holzer A, Andel D, Spiss CK, Zimpfer M, et al. Awake nasotracheal fiberoptic intubation: patient comfort, intubating conditions, and haemodynamic stability during conscious sedation with remifentanil. Anesthesia and Analgesia 2003;97:904–8. [MEDLINE: 12933427]
Maroof 2005
Rai 2008
  • Rai MR, Parry TM, Dombrovskis A, Warner OJ. Remifentanil target-controlled infusion vs propofol target-controlled infusion for conscious sedation for awake fibreoptic intubation: a double-blinded randomized controlled trial. British Journal of Anaesthesia 2008;100:125–30. [MEDLINE: 18037667]
RevMan 5.1 [Computer program]
  • The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
Rucker 2008
Venn 2000
Virtanen 1988

References to other published versions of this review

  1. References to studies included in this review
  2. References to studies excluded from this review
  3. References to studies awaiting assessment
  4. Additional references
  5. References to other published versions of this review
He 2012
  • He X, Shi X, He Q. Dexmedetomidine for the management of fibreoptic intubation. Cochrane Database of Systematic Reviews 2012, Issue 4. [DOI: 10.1002/14651858.CD009798]